Home > News > NanoSystems And B-M Squibb Agreement For NanoCrystal Technology
September 30th, 2003
NanoSystems And B-M Squibb Agreement For NanoCrystal Technology
Elan Corporation announced today that its drug delivery business unit, NanoSystems, and Bristol-Myers Squibb have signed a license agreement for NanoCrystal(TM) technology. This license will provide Bristol-Myers Squibb with access to NanoCrystal technology and the right to develop and commercialize products incorporating this technology.
Aptasensors Help Detection of Cancer Protein Marker March 9th, 2014
Nano Labs Shareholder Update March 8th, 2014
MANA Research Highlight: Smart nanofibers to treat kidney failure March 6th, 2014
Harris & Harris Group, Inc. Establishes and Invests $350,001 in ProMuc, Inc. March 6th, 2014